Luke Halpern

Articles

FDA Greenlights Low-Dose Clorthalidone (12.5 mg) for Treatment of Hypertension in Adults

May 08, 2025

Low-dose clorthalidone offers clinicians a new option for initiating treatment that may mitigate well-known metabolic adverse effects.

Insulin Prescription Fills Up Following Inflation Reduction Act Cap on Out-of-Pocket Costs

July 31, 2023

The new policy is helping people who are taking insulin save money and helping others to afford it in the first place, says a study coauthor from the USC Sol Price School of Public Policy .